17:03 EDT AIM ImmunoTech files to sell 9.98M shares of common stock for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AIM:
- AIM ImmunoTech Announces Release of the Next CEO Corner Segment
- AIM ImmunoTech announces reslease of CEO Corner segment
- AIM ImmunoTech appoints Lapp as a consulting Medical Officer
- AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs
- AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer